原代肝细胞脂肪变性细胞模型的构建

doi:10.3969/j.issn.1674-490X.2021.02.001

医学研究与教育 ›› 2021, Vol. 38 ›› Issue (2): 1-7.DOI: 10.3969/j.issn.1674-490X.2021.02.001

• 基础医学 • 下一篇

原代肝细胞脂肪变性细胞模型的构建

梁蕊,滕景芳,李钊,徐文斌,孟明

1.河北大学基础医学院, 河北保定 071000;
2.河北省炎性自身免疫性疾病发病机制及防治重点实验室, 河北保定 071000

收稿日期:2021-01-23 出版日期:2021-04-25 发布日期:2021-04-25
通讯作者: 孟明( 1964—),女,辽宁义县人,教授,博士,博士生导师,主要从事自身免疫疾病及免疫药理学研究。E-mail: mengming127@163.com
作者简介:梁蕊(1995—),女,河北沧州人,在读硕士。
基金资助:
国家自然科学基金面上项目(81771755);河北省自然科学基金(H2020201022,H2020201300)

Received:2021-01-23 Online:2021-04-25 Published:2021-04-25

摘要/Abstract

摘要： 目的为非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)发病机制和防治研究提供可靠的原代肝细胞脂肪变性细胞模型。方法采用Seglen两步灌流法及其改良方法分离获取小鼠原代肝细胞,体外培养48 h后,给予不同浓度的游离脂肪酸(free fatty acid,FFA)混合物(油酸∶棕榈酸=2∶1)诱导24 h,采用油红O染色,观察肝细胞内脂滴沉积情况,全自动生化分析仪测定细胞内三酰甘油(TG)含量。结果与对照组相比,模型组肝细胞内出现红色脂滴沉积,且与加入的FFA混合物浓度呈剂量依赖性;模型组肝细胞内TG含量明显高于对照组(P<0.05),且随着加入的FFA浓度升高而增加,提示肝细胞内脂质沉积随着加入的FFA浓度升高而增加。结论成功构建了原代肝细胞脂肪变性细胞模型,为NAFLD的研究提供了可靠的细胞模型。

关键词: 非酒精性脂肪性肝病, 原代肝细胞, 肝脂肪变性细胞模型

Abstract: Objective To provide a reliable primary hepatocyte steatosis cell model for the pathogenesis, prevention and treatment of non-alcoholic fatty liver disease(NAFLD).Methods Primary mouse hepatocytes were isolated by Seglen two-step perfusion method and its improved method.After cultured in vitro for 48 hours, different concentrations of free fatty acid(FFA)mixture ［oleic acid(OA)∶palmitic acid(PA)=2∶1］ were induced for 24 hours.The lipid droplet deposition in hepatocytes was observed by oil red O staining and the content of triglyceride(TG)in cells was determined by automatic biochemical analyzer.Results Compared with the control group, there were red lipid droplets in hepatocytes in the model group, and the concentration of FFA mixture was dose-dependent, and the content of TG in hepatocytes in the model group was significantly higher than that in the control group(P<0.05), and increased with the increase of the concentration of FFA, suggesting that the lipid deposition in hepatocytes increased with the increase of FFA concentration.Conclusion The primary hepatocyte steatosis cell model is successfully established, which provides a reliable cell model for the study of non-alcoholic fatty liver disease.

Key words: nonalcoholic fatty liver disease(NAFLD), primary hepatocytes, hepatic steatosis cell model

中图分类号:

R363.2

梁蕊, 滕景芳, 李钊, 徐文斌, 孟明. 原代肝细胞脂肪变性细胞模型的构建[J]. 医学研究与教育, 2021, 38(2): 1-7.

参考文献

[1] 于文雪, 孙禹欣, 金莉莉, 等.NAFLD的发病机制与新型治疗药物研发[J].中国细胞生物学学报, 2020, 42(3): 499-506.DOI: 10.11844/cjcb.2020.03.0016.
[2] 冯秋琪, 任国艳, 乔香君, 等.脂肪肝细胞模型的研究进展[J].中国细胞生物学学报, 2020, 42(12): 2256-2265.
[3] CARR R M, ORANU A, KHUNGAR V.Nonalcoholic fatty liver disease: pathophysiology and management[J].Gastroenterol Clin North Am, 2016, 45(4): 639-652.DOI: 10.1016/j.gtc.2016.07.003.
[4] FAN J G, KIM S U, WONG V W.New trends on obesity and NAFLD in Asia[J].J Hepatol, 2017, 67(4): 862-873.DOI: 10.1016/j.jhep.2017.06.003.
[5] LI J, ZOU B Y, YEO Y H, et al.Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis[J].Lancet Gastroenterol Hepatol, 2019, 4(5): 389-398.DOI: 10.1016/S2468-1253(19)30039-1.
[6] ZHOU F, ZHOU J, WANG W, et al.Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and Meta-analysis[J].Hepatology, 2019, 70(4): 1119-1133.DOI: 10.1002/hep.30702.
[7] 黄海燕, 辛永宁, 姜曼, 等.非酒精性脂肪性肝病动物实验模型研究进展[J].临床肝胆病杂志, 2014, 30(9): 948-953.DOI: 10.3969/j.issn.1001-5256.2014.09.028.
[8] LAU J K, ZHANG X, YU J.Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances[J].J Pathol, 2017, 241(1): 36-44.DOI: 10.1002/path.4829.
[9] FEBBRAIO M A, REIBE S, SHALAPOUR S, et al.Preclinical models for studying NASH-driven HCC: how useful are they?[J].Cell Metab, 2019, 29(1): 18-26.DOI: 10.1016/j.cmet.2018.10.012.
[10] 李妍, 蔡晓波, 陆伦根.脂肪性肝病动物模型研究进展[J].国际消化病杂志, 2019, 39(3): 157-161.DOI: 10.3969/j.issn.1673-534X.2019.03.004.
[11] 刘楠楠, 李虎, 彭宗根.肝脂肪变性细胞实验模型与机制研究进展[J].国际药学研究杂志, 2019, 46(3): 171-175.DOI: 10.13220/j.cnki.jipr.2019.03.002.
[12] HE Y, YANG W H, GAN L L, et al.Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway[J].Gastroenterol Hepatol, 2020: S0210-5705(20)30395-2.DOI: 10.1016/j.gastrohep.2020.09.014.
[13] GÓMEZ-LECHÓN M J, DONATO M T, MARTÍNEZ-ROMERO A, et al.A human hepatocellular in vitro model to investigate steatosis[J].Chem Biol Interact, 2007, 165(2): 106-116.DOI: 10.1016/j.cbi.2006.11.004.
[14] HARRIS A J, DIAL S L, CASCIANO D A.Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells[J].Mutat Res, 2004, 549(1/2): 79-99.DOI: 10.1016/j.mrfmmm.2003.11.014.
[15] MATHIJS K, KIENHUIS A S, BRAUERS K J, et al.Assessing the metabolic competence of sandwich-cultured mouse primary hepatocytes[J].Drug Metab Dispos, 2009, 37(6): 1305-1311.DOI: 10.1124/dmd.108.025775.
[16] COULON S, LEGRY V, HEINDRYCKX F, et al.Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models[J].Hepatology, 2013, 57(5): 1793-1805.DOI: 10.1002/hep.26219.
[17] YIN Z H, ELLIS E C, NOWAK G.Isolation of mouse hepatocytes for transplantation: a comparison between antegrade and retrograde liver perfusion[J].Cell Transplant, 2007, 16(8): 859-865.DOI: 10.3727/000000007783465235.
[18] 陈阳洁, 高柯欣, 王智豪, 等.小鼠肝实质细胞的分离、鉴定及原代培养[J].畜牧与饲料科学, 2019, 40(4): 7-11.DOI: 10.16003/j.cnki.issn1672-5190.2019.04.002.
[19] SCHAART G, HESSELINK R P, KEIZER H A, et al.A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections[J].Histochem Cell Biol, 2004, 122(2): 161-169.DOI: 10.1007/s00418-004-0690-0.
[20] WU J, MENG Z J, JIANG M, et al.Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells[J].Hepatology, 2009, 49(4): 1132-1140.DOI: 10.1002/hep.22751.
[21] 晏贤春, 胡彬, 王赫, 等.游离脂肪酸诱导小鼠肝实质细胞体外脂肪化并加速细胞凋亡[J].肝脏, 2013, 18(5): 306-309.DOI: 10.3969/j.issn.1008-1704.2013.05.007.
[22] SHIN S K, CHO H W, SONG S E, et al.Catalase and nonalcoholic fatty liver disease[J].Pflugers Arch-Eur J Physiol, 2018, 470(12): 1721-1737.DOI: 10.1007/s00424-018-2195-z.
[23] STEFAN N, HÄRING H U, CUSI K.Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies[J].Lancet Diabetes Endocrinol, 2019, 7(4): 313-324.DOI: 10.1016/S2213-8587(18)30154-2.
[24] GREEN C J, PRAMFALK C, MORTEN K J, et al.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations[J].Am J Physiol Endocrinol Metab, 2015, 308(1): E1-E20.DOI: 10.1152/ajpendo.00192.2014.
[25] 周萍, 樊静, 梁韡.一种简易小鼠原代肝细胞分离方法[J].成都大学学报(自然科学版), 2016, 35(4): 328-330.DOI: 10.3969/j.issn.1004-5422.2016.04.004.
[26] 吕建军, 李耀庭, 周舒雅, 等.建立原代小鼠肝细胞体外模型用于致癌物作用机制研究[J].药物分析杂志, 2016, 36(10): 1785-1797.DOI: 10.16155/j.0254-1793.2016.10.12.

原代肝细胞脂肪变性细胞模型的构建

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价